Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan.
作者信息
Viansone Alessandro A, Ammari Samy, Dercle Laurent, Arnedos Monica
机构信息
Breast Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
Breast Unit-Oncology Unit, Department of Medicine, University Hospital of Parma, Parma, Italy.
出版信息
Front Oncol. 2021 May 28;11:560585. doi: 10.3389/fonc.2021.560585. eCollection 2021.
Abstract
In late 2019 and early 2020, the world witnessed the outbreak of the SARS-CoV-2 (also referred as COVID-19) in Wuhan, China. Its rapid expansion worldwide and its contagiousness rate have forced the activation of several measures to contain the pandemic, mostly through confinement and identification of infected patients and potential contacts by testing.
摘要
相似文献
1
Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan.
Front Oncol. 2021 May 28;11:560585. doi: 10.3389/fonc.2021.560585. eCollection 2021.
2
The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19.抗原检测在预测 COVID-19 传染性方面的作用。
Microbiol Spectr. 2022 Apr 27;10(2):e0196221. doi: 10.1128/spectrum.01962-21. Epub 2022 Mar 29.
3
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.伴有非重症 COVID-19 的肿瘤患者接受全身性抗癌治疗的安全性：一项队列研究。
BMC Cancer. 2021 May 20;21(1):578. doi: 10.1186/s12885-021-08349-8.
4
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
5
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
6
[Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].[用于呼吸道样本中检测严重急性呼吸综合征冠状病毒2的快速抗原检测试剂盒与聚合酶链反应的评估]
Mikrobiyol Bul. 2022 Apr;56(2):263-273. doi: 10.5578/mb.20229806.
7
The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan, China.中国武汉一例合并 COVID-19 的结肠癌患者的积极外科治疗及转归。
BMC Gastroenterol. 2020 Aug 14;20(1):269. doi: 10.1186/s12876-020-01411-y.
8
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.中药治疗重症 COVID-19 患者的疗效和安全性评估：中国 COVID-19 疫情早期武汉的回顾性病例系列研究。
J Ethnopharmacol. 2021 Sep 15;277:113888. doi: 10.1016/j.jep.2021.113888. Epub 2021 Jan 30.
9
Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.马德里 COVID-19 大流行期间的乳腺癌管理：手术策略。
Clin Breast Cancer. 2021 Feb;21(1):e128-e135. doi: 10.1016/j.clbc.2020.10.006. Epub 2020 Oct 24.
10
Thoracic computerised tomography scans in one hundred eighteen orthopaedic patients during the COVID-19 pandemic: identification of chest lesions; added values; help in managing patients; burden on the computerised tomography scan department.COVID-19 大流行期间 118 例骨科患者的胸部计算机断层扫描：胸部病变的检出；附加价值；帮助管理患者；对计算机断层扫描部门的负担。
Int Orthop. 2020 Aug;44(8):1571-1580. doi: 10.1007/s00264-020-04651-5. Epub 2020 Jun 7.
本文引用的文献
1
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.德国综合癌症中心的血液系统恶性肿瘤和实体瘤患者中的新冠病毒感染。
Cancer Med. 2020 Nov;9(22):8412-8422. doi: 10.1002/cam4.3460. Epub 2020 Sep 15.
2
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis.非危重症 COVID-19 患者肺栓塞的发生率。具有挑战性诊断的预测因素。
J Thromb Thrombolysis. 2021 Jan;51(1):40-46. doi: 10.1007/s11239-020-02190-9.
3
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid.西班牙马德里一家医院在疫情首个月期间癌症患者的新冠病毒传播、结果及其相关风险因素。
Clin Transl Oncol. 2020 Dec;22(12):2364-2368. doi: 10.1007/s12094-020-02381-z. Epub 2020 May 25.
4
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
5
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.纽约医院系统中 COVID-19 癌症患者的病死率。
Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1.
6
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
7
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
8
Global guidance for surgical care during the COVID-19 pandemic.全球 COVID-19 大流行期间外科护理指南。
Br J Surg. 2020 Aug;107(9):1097-1103. doi: 10.1002/bjs.11646. Epub 2020 Apr 15.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.国家监管机构关于在新冠疫情期间正在进行的癌症试验的建议。
Lancet Oncol. 2020 May;21(5):624-627. doi: 10.1016/S1470-2045(20)30226-6. Epub 2020 Apr 8.
Zotero 插件